Package 0832-1074-90

{"route": ["ORAL"], "spl_id": "4c23c6e3-1684-b1fd-e063-6394a90a99a6", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0308321072301", "0308321074305"], "unii": ["0H73WJJ391"], "rxcui": ["1494769", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["691d276c-9cc1-4d39-828f-0f44d7ef6328"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-1074-15)", "package_ndc": "0832-1074-15", "marketing_start_date": "20140707"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0832-1074-30)  / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0832-1074-30", "marketing_start_date": "20140707"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0832-1074-90)  / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "0832-1074-90", "marketing_start_date": "20140707"}], "brand_name": "Topiramate", "product_id": "0832-1074_4c23c6e3-1684-b1fd-e063-6394a90a99a6", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0832-1074", "generic_name": "Topiramate", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "NDA205122", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140707", "listing_expiration_date": "20271231"}